110 related articles for article (PubMed ID: 24351783)
1. A review of the impact of preoperative chemoradiotherapy on outcome and postoperative complications in esophageal cancer patients.
Wilke TJ; Bhirud AR; Lin C
Am J Clin Oncol; 2015 Aug; 38(4):415-21. PubMed ID: 24351783
[TBL] [Abstract][Full Text] [Related]
2. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
Wang SL; Liao Z; Vaporciyan AA; Tucker SL; Liu H; Wei X; Swisher S; Ajani JA; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):692-9. PubMed ID: 16242257
[TBL] [Abstract][Full Text] [Related]
3. Serum Transforming Growth Factor-β1 Change After Neoadjuvant Chemoradiation Therapy Is Associated With Postoperative Pulmonary Complications in Esophageal Cancer Patients Undergoing Combined Modality Therapy.
Lu SL; Hsu FM; Tsai CL; Wu JK; Lee JM; Huang PM; Hsu CH; Koong AC; Chang DT; Cheng JC
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1023-31. PubMed ID: 26475065
[TBL] [Abstract][Full Text] [Related]
4. [Dosimetric factors related to postoperative pulmonary complications in locally advanced esophageal cancers treated with preoperative chemoradiotherapy: Literature review].
Dworczak M; Le Deley MC; Adenis A; Piessen G; Lartigau É; Mirabel X; Lacornerie T; Pasquier D
Bull Cancer; 2020 Oct; 107(10):982-990. PubMed ID: 32977935
[TBL] [Abstract][Full Text] [Related]
5. [Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial].
Fu JH; Rong TH; Li XD; Hu Y; Ou W; Hu YH; Li Q
Ai Zheng; 2004 Nov; 23(11 Suppl):1473-6. PubMed ID: 15566661
[TBL] [Abstract][Full Text] [Related]
6. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters.
Lee HK; Vaporciyan AA; Cox JD; Tucker SL; Putnam JB; Ajani JA; Liao Z; Swisher SG; Roth JA; Smythe WR; Walsh GL; Mohan R; Liu HH; Mooring D; Komaki R
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1317-22. PubMed ID: 14630268
[TBL] [Abstract][Full Text] [Related]
7. Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients.
Bosch DJ; Muijs CT; Mul VE; Beukema JC; Hospers GA; Burgerhof JG; Plukker JT
Ann Surg Oncol; 2014 Feb; 21(2):605-11. PubMed ID: 24100962
[TBL] [Abstract][Full Text] [Related]
8. Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
Tucker SL; Liu HH; Wang S; Wei X; Liao Z; Komaki R; Cox JD; Mohan R
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):754-61. PubMed ID: 16965865
[TBL] [Abstract][Full Text] [Related]
9. Choosing the best treatment for esophageal cancer : criteria for selecting the best multimodal therapy.
Hölscher AH; Bollschweiler E
Recent Results Cancer Res; 2012; 196():169-77. PubMed ID: 23129373
[TBL] [Abstract][Full Text] [Related]
10. Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer.
Ruol A; Portale G; Castoro C; Merigliano S; Cagol M; Cavallin F; Chiarion Sileni V; Corti L; Rampado S; Costantini M; Ancona E
Ann Surg Oncol; 2007 Nov; 14(11):3243-50. PubMed ID: 17713823
[TBL] [Abstract][Full Text] [Related]
11. Induction therapy does not increase surgical morbidity after esophagectomy for cancer.
Lin FC; Durkin AE; Ferguson MK
Ann Thorac Surg; 2004 Nov; 78(5):1783-9. PubMed ID: 15511475
[TBL] [Abstract][Full Text] [Related]
12. [Radiochemotherapy for esophageal cancer: which nodes should be irradiated?].
Créhange G; Quivrin M; Vulquin N; Serre AA; Maingon P
Cancer Radiother; 2014 Oct; 18(5-6):577-82. PubMed ID: 25201634
[TBL] [Abstract][Full Text] [Related]
13. Definitive chemoradiotherapy for esophageal carcinoma.
Cooper SL; Russo JK; Chin S
Surg Clin North Am; 2012 Oct; 92(5):1213-48. PubMed ID: 23026279
[TBL] [Abstract][Full Text] [Related]
14. Induction chemoradiotherapy increases pleural and pericardial complications after esophagectomy for cancer.
Murthy SC; Rozas MS; Adelstein DJ; Mason DP; Calhoun R; Rybicki LA; Feng J; Blackstone EH; Rice TW
J Thorac Oncol; 2009 Mar; 4(3):395-403. PubMed ID: 19247086
[TBL] [Abstract][Full Text] [Related]
15. Preoperative chemoradiation therapy for esophageal cancer is a risk factor for the elevation of high mobility group box-1, leading to an increase in postoperative severe pulmonary complications.
Takahata R; Ono S; Tsujimoto H; Hiraki S; Aosasa S; Yamamoto J; Hase K
Dis Esophagus; 2016 Jan; 29(1):70-8. PubMed ID: 25139532
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma.
Blazeby JM; Sanford E; Falk SJ; Alderson D; Donovan JL
Cancer; 2005 May; 103(9):1791-9. PubMed ID: 15779022
[TBL] [Abstract][Full Text] [Related]
17. Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients.
Smit JK; Güler S; Beukema JC; Mul VE; Burgerhof JG; Hospers GA; Plukker JT
Ann Surg Oncol; 2013 Nov; 20(12):4008-15. PubMed ID: 23838922
[TBL] [Abstract][Full Text] [Related]
18. Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEER-Medicare analysis.
Hong JC; Murphy JD; Wang SJ; Koong AC; Chang DT
Ann Surg Oncol; 2013 Nov; 20(12):3999-4007. PubMed ID: 23800897
[TBL] [Abstract][Full Text] [Related]
19. Impact of neoadjuvant chemoradiotherapy on postoperative outcomes after esophageal cancer resection: results of a European multicenter study.
Gronnier C; Tréchot B; Duhamel A; Mabrut JY; Bail JP; Carrere N; Lefevre JH; Brigand C; Vaillant JC; Adham M; Msika S; Demartines N; El Nakadi I; Piessen G; Meunier B; Collet D; Mariette C; ; Luc G; Cabau M; Jougon J; Badic B; Lozach P; Cappeliez S; Lebreton G; Alves A; Flamein R; Pezet D; Pipitone F; Iuga BS; Contival N; Pappalardo E; Mantziari S; Hec F; Vanderbeken M; Tessier W; Briez N; Fredon F; Gainant A; Mathonnet M; Bigourdan JM; Mezoughi S; Ducerf C; Baulieux J; Pasquer A; Baraket O; Poncet G; Vaudoyer D; Enfer J; Villeneuve L; Glehen O; Coste T; Fabre JM; Marchal F; Frisoni R; Ayav A; Brunaud L; Bresler L; Cohen C; Aze O; Venissac N; Pop D; Mouroux J; Donici I; Prudhomme M; Felli E; Lisunfui S; Seman M; Petit GG; Karoui M; Tresallet C; Ménégaux F; Hannoun L; Malgras B; Lantuas D; Pautrat K; Pocard M; Valleur P
Ann Surg; 2014 Nov; 260(5):764-70; discussion 770-1. PubMed ID: 25379847
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal cancer in a single high-volume center.
Zanoni A; Verlato G; Giacopuzzi S; Weindelmayer J; Casella F; Pasini F; Zhao E; de Manzoni G
Ann Surg Oncol; 2013 Jun; 20(6):1993-9. PubMed ID: 23274533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
